India sulbactam market is expected to grow at a steady rate during
the forecast period. The bacterial cells produce β-lactamase which reduces the
antibiotic activity and helps the bacteria to develop resistance against that
particular antibiotic. Sulbactam here serves as a β-lactamase inhibitor which
binds to the enzyme and does not allow it to degrade the antibiotic. This in
turn has increased the demand for sulbactam, which is being used in combination
with broad spectrum antibiotics like ampicillin. This in turn is expected to positively influence the
market growth through FY2026. Additionally, supportive government policies and
schemes such as production linked incentive scheme for indigenous manufacturing
of APIs, establishment of bulk drug parks, among others launched by the
government of India are expected to create lucrative opportunities for the
market growth over the next few years.
The India Sulbactam market is segmented
based on composition, source, form, distribution channel, application, end
user, company and region. Based on source, the market can be split into in-house
and contract manufacturing organizations. The contract manufacturing
organizations segment is expected to witness significant growth during the
forecast period. This can be attributed to the increased outsourcing activities
by the major companies in order to focus on their R&D activity and
expansion plans. Additionally, contract manufacturing organizations offer
greater customer satisfaction, competitive pricing and can provide bulk orders
in lesser duration.
The major players operating in the India
sulbactam market are Fresenius Kabi India Pvt. Ltd., M N Pharmaceuticals Pvt.
Ltd., Morepen Laboratories Ltd., Unichem
Laboratories Ltd., Hospira Healthcare India Pvt. Ltd., AdvaCare Pharma LLP, Innovexia Lifesciences Private Limited, Osper
Pharmaceuticals Pvt. Ltd., Torrent Laboratories Pvt. Ltd., Glenmark
Pharmaceuticals Ltd. and others. Major companies are developing advanced
technologies, receiving approvals from regulatory bodies and launching new products
in order to stay competitive in the market. Other competitive strategies
include mergers & acquisitions and new product developments.
Years
considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the Study:
- To analyze and estimate the market size of India sulbactam market
from FY2016 to FY2019.
- To estimate and forecast the market size of India sulbactam market
from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India sulbactam market based on composition,
source, form, distribution channel, application, end user, company and
regional distribution.
- To identify dominant region or segment in the India sulbactam market.
- To identify drivers and challenges for India sulbactam market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in India sulbactam market.
- To identify and analyze the profile of leading players operating in
India sulbactam market.
- To identify key sustainable strategies adopted by market players in
India sulbactam market.

Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufacturers,
distribution channels and presence of all major players across the globe.
TechSci
Research calculated the market size of India sulbactam market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.

Key Target Audience:
- Sulbactam manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
sulbactam
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, India sulbactam market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Sulbactam Market, By Composition:
- India Sulbactam Market, By Source:
- In-House
- Contract
Manufacturing Organizations
- India Sulbactam Market, By Form:
- Intramuscular
Injection
- Intravenous
Injection
- Powder
Solution
- Others
- India Sulbactam Market, By Distribution Channel:
- India Sulbactam Market, By Application:
- Respiratory
Infections
- Skin
Infections
- Urinary
Infections
- Others
- India Sulbactam Market, By End User:
- India Sulbactam Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India sulbactam market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
India Sulbactam market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]